CHASX
Price
$20.06
Change
+$0.30 (+1.52%)
Updated
Aug 7 closing price
Net Assets
161.39M
RGAHX
Price
$87.27
Change
+$0.81 (+0.94%)
Updated
Aug 7 closing price
Net Assets
356.86B
Interact to see
Advertisement

CHASX vs RGAHX

CHASX vs RGAHX Comparison Chart in %
View a ticker or compare two or three
VS
CHASX vs. RGAHX commentary
Aug 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHASX is a StrongBuy and RGAHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 357B vs. CHASX (161M). RGAHX pays higher dividends than CHASX: RGAHX (0.41) vs CHASX (0.00). CHASX was incepted earlier than RGAHX: CHASX (29 years) vs RGAHX (11 years). CHASX (1.29) is less costly to investors than RGAHX (0.44). CHASX is a more actively managed with annual turnover of: 107.00 vs. RGAHX (32.00). RGAHX has a lower initial minimum investment than CHASX: RGAHX (250) vs CHASX (2000). CHASX annual gain was more profitable for investors over the last year : 28.75 vs. RGAHX (6.01). CHASX return over 5 years is better than : 26.56 vs. RGAHX (17.40).
CHASXRGAHXCHASX / RGAHX
Total Expense Ratio1.150.44261%
Annual Report Gross Expense Ratio1.290.44293%
Fund Existence29 years11 years-
Gain YTD26.96210.134266%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets161M357B0%
Annual Yield % from dividends0.000.41-
Returns for 1 year28.756.01478%
Returns for 3 years68.0144.32153%
Returns for 5 years26.5617.40153%
Returns for 10 years57.58104.5755%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMDZX6.950.16
+2.36%
Virtus Silvant Mid-Cap Growth R6
VSMAX146.651.97
+1.36%
Vanguard Morn Small Cap Index Admiral
MWEIX45.790.37
+0.81%
MFS Global Equity I
TSTFX18.030.11
+0.61%
Transamerica Stock Index R4
JEPAX14.31-0.01
-0.07%
JPMorgan Equity Premium Income A